Trinity Biotech plc Announces Details of Its Dividend and Share Buyback Program

Trinity Biotech plc

announced additional details of its Dividend and Share Buyback Program. Annual Dividend At its most recent AGM held on 25 May, 2012, Trinity Biotech obtained shareholder approval to pay a dividend of US 15 cents per ADR. The dividend will have a record date of Friday June 8, 2012 with payment to follow two weeks later on Friday June 22, 2012. Share buyback At the same meeting, the shareholders also renewed their approval for the Company to repurchase its own shares, up to a maximum of 10% of the outstanding shares at the date of the meeting. This authority is valid for an 18 month period commencing on the date of the meeting and is capable of being renewed at any future General Meeting. Following this approval, the Board of the Company has determined to continue to repurchase shares in the market, up to the maximum level approved. The approval granted allows for up to 10% of the issued shares of the Company, or 2.1m ADRs, to be repurchased which, based on current market prices, equates to up to approximately $23m. The levels of these repurchases, which will be determined by the Board at regular intervals, will depend on market conditions at the time, in particular the prevailing share price and trading volumes.